Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ACTRN12625001444471) titled 'Optimal Timing for Adolescent Meningococcal B vaccination schedule (BOOST MenB study)' on Dec. 19, 2025.
Study Type: Interventional
Study Design:
Purpose: Prevention
Allocation: Randomised controlled trial
Masking: Open (masking not used)
Assignment: Parallel
Type of endpoint: Efficacy
Primary Sponsor: University of Adelaide
Condition:
Immune Response to meningococcal vaccination
Meningococcal immunity
Immune Response to meningococcal vaccination
Meningococcal immunity
Infection - Other infectious diseases
Public Health - Other public health
Intervention:
The intervention is the extended-interval 4CMen...